Mannitol Unknown Status Phase 3 Trials for Malaria, Cerebral Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00113854Mannitol as Adjunct Therapy for Childhood Cerebral Malaria